Rockwell Medical Stock News

WIXOM, Mich., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment

Rockwell Medical Inc (RMTI) shares closed today 10.8% higher than it did at the end of yesterday. The stock is currently down 63.4% year-to-date, down 60.9% over the past 12 months, and down 94.3% over the past five years. Today, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 fell 0.3%. Trading Activity Shares traded as high as $0.43 and as low as $0.34 this week.Shares closed 79.3% below its 52-week high and 19.9% above its 52-week low.Trading volume this week was 45.8% higher than the 10-day average and 69.4% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.4. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -962.2% The company's stock price performance over the past 12 months lags the peer average by -812.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Rockwell Medical Inc (RMTI) shares closed 0.3% lower than its previous 52 week low, giving the company a market cap of $34M. The stock is currently down 63.2% year-to-date, down 61.4% over the past 12 months, and down 94.3% over the past five years. This week, the Dow Jones Industrial Average rose 2.6%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 23.1% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.4. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -949.8% The company's stock price performance over the past 12 months lags the peer average by -742.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Rockwell Medical Inc (RMTI) shares closed 0.2% lower than its previous 52 week low, giving the company a market cap of $35M. The stock is currently down 62.4% year-to-date, down 62.4% over the past 12 months, and down 94.2% over the past five years. This week, the Dow Jones Industrial Average rose 3.9%, and the S&P 500 rose 4.9%. Trading Activity Trading volume this week was 28.2% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.4. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -877.1% The company's stock price performance over the past 12 months lags the peer average by -735.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Rockwell Medical, Inc. (NASDAQ:RMTI) with the stream of -8.58% also noticed, India The Kroger Co. (NYSE:KR) encountered a rapid change of -0.11% in the last hour of Tuesdays trading session. The post Volatile Stock to Watch: Rockwell Medical, Inc. (NASDAQ:RMTI), The Kroger Co. (NYSE:KR) appeared first on Stocks Equity .

WIXOM, Mich., Dec. 14, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that it received feedback from the U.S. Food and Drug Administration (FDA) regarding its Investigational New Drug (IND) application in support of its proposed Phase 2 clinical trial of Ferric Pyrophosphate Citrate (FPC), designed for the treatment of iron deficiency anemia and maintenance of hemoglobin in patients receiving infusion therapy in the home setting.

AQR Capital Management LLC trimmed its position in Rockwell Medical, Inc. (NASDAQ:RMTI) by 88.6% in the second quarter, according to its most recent filing with the SEC. The institutional investor owned 83,668 shares of the companys stock after selling 647,163 shares during the period. AQR Capital Management LLCs holdings in Rockwell Medical were worth $76,000 []

Geode Capital Management LLC reduced its stake in Rockwell Medical, Inc. (NASDAQ:RMTI) by 42.8% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 711,373 shares of the companys stock after selling 533,117 shares during the quarter. Geode Capital Management LLC owned 0.76% of []

Rockwell Medical, Inc. (RMTI) with the stream of -3.13% also noticed, India ECMOHO Limited (MOHO) encountered a rapid change of 3.44% in the last hour of Fridays trading session. Rockwell The post Remarkable Stock in Review: Rockwell Medical, Inc. (NASDAQ:RMTI), ECMOHO Limited (NASDAQ:MOHO) appeared first on Stocks Equity .

Rockwell Medical (NASDAQ:RMTI) issued its quarterly earnings results on Monday. The company reported ($0.08) earnings per share for the quarter, missing the Zacks consensus estimate of ($0.07) by ($0.01), MarketWatch Earnings reports. Rockwell Medical had a negative return on equity of 106.66% and a negative net margin of 52.69%. During the same quarter in the []

Toward the end of trading Wednesday, the Dow traded down 0.58% to 35,930.89 while the NASDAQ fell 0.27% to 15,930.79. The SP also fell, dropping 0.23% to 4,690.24. The U.S. has the highest number of

Rockwell Medical Inc (NASDAQ: RMTI) has announced the publication of results in the Journal of Bioequivalence & Bioavailability from a study evaluating the co-administration of intravenous (IV) Fer

The shares of Rockwell Medical Inc (NASDAQ: RMTI) increased by over 55% pre-market today. This is why it happened.

Findings confirm results from previous population PK study demonstrating safe and effective anticoagulation along with the delivery of Ferric Pyrophosphate Citrate iron Findings confirm results from previous population PK study demonstrating safe and effective anticoagulation along with the delivery of Ferric Pyrophosphate Citrate iron